批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2018/08/20 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/11/15 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/09/30 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/10/11 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/09/27 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2009/03/03 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/03/03 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/03/03 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/09/26 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/11/08 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:FROVATRIPTAN SUCCINATE 剂型/给药途径:TABLET;ORAL 规格:EQ 2.5MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021006 |
001 |
NDA |
FROVA |
FROVATRIPTAN SUCCINATE |
TABLET;ORAL |
EQ 2.5MG BASE |
Prescription |
Yes |
Yes |
AB |
2001/11/08
|
ENDO OPERATIONS |
202931 |
001 |
ANDA |
FROVATRIPTAN SUCCINATE |
FROVATRIPTAN SUCCINATE |
TABLET;ORAL |
EQ 2.5MG BASE |
Discontinued |
No |
No |
AB |
2014/08/28
|
NORVIUM BIOSCIENCE |
204730 |
001 |
ANDA |
FROVATRIPTAN SUCCINATE |
FROVATRIPTAN SUCCINATE |
TABLET;ORAL |
EQ 2.5MG BASE |
Prescription |
No |
No |
AB |
2016/03/11
|
GLENMARK PHARMS LTD |
211292 |
001 |
ANDA |
FROVATRIPTAN SUCCINATE |
FROVATRIPTAN SUCCINATE |
TABLET;ORAL |
EQ 2.5MG BASE |
Prescription |
No |
No |
AB |
2018/11/06
|
AMNEAL PHARMS CO |
213891 |
001 |
ANDA |
FROVATRIPTAN SUCCINATE |
FROVATRIPTAN SUCCINATE |
TABLET;ORAL |
EQ 2.5MG BASE |
Prescription |
No |
No |
AB |
2022/04/06
|
RENATA |